
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
An integrative integrative psychiatrist provides practical guidance for incorporating complementary and alternative medicine into psychiatric practice in the treatment of severe mental illness.




